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OBJECTIVE: During cardiac surgery, several factors contribute to the development of postoperative pulmonary
complications. Non-invasive ventilation is a promising therapeutic tool for improving the functionality of this
type of patient. The aim of this study is to evaluate the functional capacity and length of stay of patients in a
nosocomial intensive care unit who underwent prophylactic non-invasive ventilation after heart valve replacement.
METHOD: The study was a controlled clinical trial, comprising 50 individuals of both sexes who were allocated
by randomization into two groups with 25 patients in each group: the control group and experimental group.
After surgery, the patients were transferred to the intensive care unit and then participated in standard physical
therapy, which was provided to the experimental group after 3 applications of non-invasive ventilation within
the first 26 hours after extubation. For non-invasive ventilation, the positive pressure was 10 cm H2O, with
a duration of 1 hour. The evaluation was performed on the 7th postoperative day/discharge and included a
6-minute walk test. The intensive care unit and hospitalization times were monitored in both groups. Brazilian
Registry of Clinical Trials (REBeC): RBR number 8bxdd3.
RESULTS: Analysis of the 6-minute walk test showed that the control group walked an average distance of
264.34±76 meters and the experimental group walked an average distance of 334.07±71 meters (p=0.002). The
intensive care unit and hospitalization times did not differ between the groups.
CONCLUSION: Non-invasive ventilation as a therapeutic resource was effective toward improving functionality;
however, non-invasive ventilation did not influence the intensive care unit or hospitalization times of the
studied cardiac patients.
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’ INTRODUCTION
Cardiac surgeries can cause a series of clinical and func-
tional complications that are linked to specific factors, such
as general anesthesia, median sternotomy, cardiopulmonary
bypass and thoracic manipulation. Postoperative pulmonary
complications are the most common complication type and,
in turn, contribute directly to increased morbidity and mor-
tality and longer hospital stays (1-3). These dysfunctions
alter breathing patterns, which reduces the lung volume and
capacity, and contribute to the appearance of atelectasis and
to changes in the ventilation/perfusion ratio, which reduces
the cardiorespiratory capacity and promotes physical inac-
tivity, loss of muscle strength and loss of physical condition-
ing (4,5). Thus, cardiac rehabilitation plays an important role
in the safe and effective treatment of these patients, reduces
mortality, hospitalizations and hospital costs and improves
symptoms and quality of life. A cardiac rehabilitation pro-
gram should focus on improving the physiological state,
functional ability and psychology of the patient and be based
on a multidisciplinary approach (3-6).
As an important component of this multidisciplinary
approach, physical therapy is used to both prevent and treat
complications by employing techniques and therapeutic pro-
cedures to restore a functional respiratory pattern and the
physical independence of the patient, either in the hospital
bed or on an ambulatory basis (4,7,8). Among the therapeutic
resources used, non-invasive ventilation (NIV) has shownDOI: 10.6061/clinics/2017(10)05
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satisfactory results. NIV has the main objective of provid-
ing ventilatory assistance to improve oxygenation and/or
decrease CO2 retention, which reduces breathing efforts,
anaerobic metabolism and the dyspnea index, avoiding endo-
tracheal intubation and increasing residual volume and
alveolar recruitment, thus preventing the presence of atelec-
tasis and maintaining adequate gas exchange (4,9-12). NIV
can increase physical performance in such patients by
increasing oxygenation in the microcirculation of peripheral
muscles, which reflects a better contractile performance of
the heart muscle and subsequently provides better perfusion
of peripheral tissues, including muscles; thus, exercise tole-
rance is increased (9,13-17).
Given the aforementioned data describing the use of NIV
during the cardiac postoperative period, information regard-
ing the mechanisms of action of NIV in the functional capacity
of these patients is lacking, and whether there are advantages
to NIV use as a preventive therapy during the postoperative
period is unknown. Thus, this study aimed to evaluate the
functional capacity and length of stay of patients in the noso-
comial intensive care unit (ICU) and the lengths of hospital
stays of patients after heart valve replacement who had under-
gone three prophylactic one-hour applications of NIV in CPAP
mode with a pressure level of 10 cm H2O. We hypothesized
that this therapeutic resource would improve the functional
performance of these patients.
’ MATERIALS AND METHODS
Research Setting
The study was conducted at the Cardiovascular ICU and
Cardiology Office of Charitable Foundation of Surgery
Hospital (Fundac¸ão de Beneficência Hospital de Cirurgia –
FBHC) located in Aracaju-SE, which participates in the
Brazilian Unified Health System (Sistema Único de Saúde –
SUS) as a referral for the care of cardiovascular surgery in
the state of Sergipe and in the cities of the states of Bahia
and Alagoas.
Study Design
The study was a randomized clinical trial. A quantitative
approach was used to assess the use of non-invasive mecha-
nical ventilation as a prophylactic therapeutic resource for
the functional capacity of patients in a cardiac postoperative
period.
The sample consisted of adult patients of both sexes who
were randomized into two groups (an experimental group
and a control group, with 25 patients in each group) through
an electronic system (http://randomizer.org/form.htm) as
the patients underwent hospital admission to undergo heart
valve replacement surgery. To guarantee concealment of
the allocation list, the randomization was performed by an
independent researcher (Figure 1).
Blinding
Considering the type of our intervention, it was not
possible to blind the patients and the investigators that
performed the prophylactic CPAP. However, the investiga-
tors that assessed the outcomes were blinded.
Outcomes
The primary outcome of this study was the maximum
walked distance in the six-minute walking test (6MWT),
and the secondary outcome was the length of the hospital
stay. The walking test was assessed at hospital discharge.
The length of stay was assessed at intensive care discharge
and at hospital discharge.
Figure 1 - Algorithm for patient distribution (CONSORT). Source: research data.
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Population
This study was carried out in a reference hospital for car-
diac surgery of the Brazilian Public Health System (Sistema
Único de Saúde - SUS, Fundac¸ão de Beneficência Hospital de
Cirurgia - FBHC, Aracaju, Sergipe).
The eligibility criteria were as follows: patients were
admitted to the hospital for heart valve replacement surgery;
comprised both genders; and were between 20 and 70 years
old.
The exclusion criteria were as follows: patients with motor
disabilities that prevented walking and patients with contra-
indications to CPAP, such as a decreased level of conscious-
ness, an ineffective cough, an airway obstruction, abdominal
distention, vomiting, upper gastrointestinal bleeding, acute
coronary syndrome, complex arrhythmias, facial trauma,
esophageal surgery and an undrained barotrauma.
Sources of lost tracking (discontinuity) included the fol-
lowing: early discharge from the hospital; need for reintuba-
tion; need for invasive mechanical ventilation more than
24 hours after surgery; non-invasive need for ventilation
therapeutically for reversal of respiratory failure; surgical
complications or reintervention; hemodynamic instability;
death; and removal of free and informed consent. At any time
in the study, patients from the control group who showed a
need for invasive or non-invasive ventilatory support for
dyspnea (i.e., increased respiratory rate425 bpm, paradoxical
pattern, use of accessory muscles and decrease in peripheral
saturation oxygen) were removed from the study.
Based on the eligibility criteria, 104 patients were included
in this study, and 30 patients were removed after the exclu-
sion criteria analysis. A total of 74 patients were randomized;
36 were allocated to the experimental group, and 38 were
allocated to the control group. Of these patients, 11 from the
experimental group and 13 from the control group were
affected by the research discontinuation criteria; 50 patients
remained for the final analysis of the present study and
were distributed as follows: 25 in the experimental group,
and 25 in the control group (Figure 1).
Sampling Technique
Patients were randomized into two groups (the experi-
mental group and the control group) using a randomization
process produced by an electronic system: http://randomi-
zer.org/form.htm. At the time of hospitalization, each patient
underwent a preoperative assessment and an assessment
protocol that consisted of patient identification, vital signs,
clinical diagnosis, surgery type, medical history, medications
and the preoperative ejection fraction (EF).
Postoperative revaluation was performed on the 7th posto-
perative day (POD) or at discharge. The 6MWT was perfor-
med, and the operative times, extracorporeal circulation
(ECC), ICU and hospitalization times, as well as the post-
operative EFs of both groups, were assessed.
After surgery, the patients were transferred to the ICU,
where they were subjected to the interruption process of
mechanical ventilation. The patients in the experimental
group received three applications of NIV within the first 26
hours after extubation, and the first application was per-
formed within the first 2 hours after the removal of the tube,
maintaining an interval of 12 hours between the other appli-
cations. For therapy, a positive pressure device, ResMed
S7 Lightweight in Continuous Positive pressure mode
(CPAP), and an oronasal interface were used for one hour
and adjusted with a PEEP of 10 cm of H2O (9,18). In addition
to the NIV application, patients in the experimental group
underwent the physical therapy protocol, which was perfor-
med by the hospital’s physiotherapy team based on the
guidelines of the Brazilian Society of Cardiology, throughout
their hospitalization. The control group did not undergo NIV
therapy; these patients participated in respiratory and motor
therapy only.
Instrument
The 6MWT. The 6MWT is a simple test that is easy to
perform, safe, inexpensive and consists of a patient walk-
ing 30 meters for 6 minutes in a corridor. To assess his or
her tolerance to physical exertion, the test was performed
with a brisk walk, but no running, and the patient was
verbally encouraged during each minute of the test to com-
plete the maximum distance. The Borg Scale was used
before and after the 6 minutes to verify the patient’s sub-
jective fatigue (19).
To prepare for the test, checks were performed at zero,
3 and 6 minutes. At zero minutes, vital signs such as blood
pressure (BP), heart rate (HR), respiratory rate (RR) and
oxygen saturation (SpO2) were measured. At the third
minute, only SpO2 and HR were measured because they
needed to be checked while walking, without affecting the
patient’s performance. At no time did the evaluator interrupt
the patient, which was possible with use of a pulse oximeter.
At the sixth minute, all variables were verified (BP, RR, HR
and SpO2), and the patient’s fatigue level was evaluated
immediately after termination (20,21).
Ethical Aspects
Patients only participated in the study after providing
either signed or fingerprint-marked informed consent direc-
tly or by proxy through a guardian (family and/or compa-
nion). The informed consent form consisted of a declaration
informing the subject of the research, objectives, evaluation
methods and procedures, risks and benefits.
Each patient received an explanation regarding how the
research could contribute positively to his or her recovery
process and to clarify possible doubts. The patients were
informed that they could withdraw from research participa-
tion whenever they wanted. The patients were also warned
that, at the time of the NIV application, respiratory distress
and fatigue may occur.
The study was approved by the Ethics Committee on Human
Research of Tiradentes University in accordance with the
Declaration of Helsinki under Protocol number 021211R. The
study was published in the Brazilian Registry of Clinical
Trials (REBeC) with the RBR number 8bxdd3.
Statistical Analysis
Data were categorized in Microsoft Excel 2007s spread-
sheet files, and for the statistical analysis, BioEstat 5.0 was
used. The normality condition was assessed using the Shapiro-
Wilk test. Student’s t-test was used to compare the parametric
data, and the Mann-Whitney test was used for nonparametric
samples. For comparisons of categorical variables, such as
sex, a chi-squared test was used, and p values o0.05 were
considered statistically significant.
The study by Oliveira et al. (3) was used as the basis for
the calculation of sample size. The distance walked in the
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6MWT was considered the main parameter. Assuming that
the effect size=50 meters, variability=50.66 meters, signifi-
cance level=5%, and power test=95%, a minimum sample
size of 19 patients for each group was determined.
’ RESULTS
Table 1 shows the data for the characterization of the sam-
ple relating to the experimental group and control group,
considering age, gender, pre-surgical EF of the left ventricle
(LVEF) and ECC time. The results demonstrated that there
was no statistically significant difference between the groups,
even with the homogeneity of the patients included in the
study. Table 1 shows the length of stay in the ICU and total
hospital stay times of the experimental and control groups.
Regarding the ICU times, the length of stay for the experi-
mental group length was 3 days (2, 3), and the length of stay
for the control group was 3 days (2, 3) (p=0.41). In relation to
hospitalization times, the length of stay for the experimental
group was 7 days (7, 9), and the length of stay for the control
group was 8 days (6, 5, 8) (p=0.55). These data showed that
there was no statistically significant difference between the
groups.
Figure 2 shows the 6MWT results. The experimental group
(334.07±71 meters) covered a significantly greater distance
than the control group (264.34±76 meters).
’ DISCUSSION
In this study, we evaluated the functional capacities,
lengths of stay in the ICU and lengths of stay in the hospital
of the patients after heart valve replacement and three
applications of prophylactic NIV within the first 26 hours
after extubation. The patients in the experimental group wal-
ked 334.07 meters in the 6MWT, whereas the patients from
the control group walked 264.34 meters, which represented a
significant difference. As a secondary outcome, no difference
was detected between the groups for length of stay in the
hospital or in the ICU. These findings demonstrate that
the use of CPAP in the immediate postoperative period in
patients subjected to heart valve replacement improves func-
tional activity, as evidenced by a longer distance walked in
the 6MWT at hospital discharge.
NIV has been extensively used in early-stage acute respi-
ratory failure (ARF), and the success of treatment has been
associated with the ARF type and severity, underlying disease,
application time, treatment site, and the experience of the
team (14,15,18,22-25). However, reports describing the pro-
phylactic use of NIV are lacking.
The study by Zarbock et al. (10) demonstrated that admi-
nistration of NIV for an extended period of time after cardiac
surgery improved arterial oxygenation, reduced the incidence
of pulmonary complications, including pneumonia and the
need for reintubation, and reduced the rate of readmission to
the ICU, which may explain the superior performance in the
walking test of the patients who underwent NIV in our study.
Using a similar methodological design and population,
Mazullo Filho et al. (26) carried out a randomized, controlled
study with 32 patients during the immediate postoperative
period after cardiac surgery. The experimental group used
NIV for 2 hours after extubation. The authors found an ave-
rage reduction in HR and a lower cardiac output, thus reduc-
ing the need for energy expenditure and respiratory effort,
compared to the control group, which did not use NIV. With
lower energy expenditure and lower RR than patients
without NIV, the cardiopathy patient with NIV can exhibit
better cardiopulmonary fitness and perform his or her
activities in a more functional way, which is the primary
outcome of our research.
Functional capacity has been evaluated in research studies
of patients with heart failure. The 6MWT is a useful tool for
this purpose because the test is simple and cost-effective. The
6MWT can be used to reproduce daily activities, evaluate
exercise tolerance, assess the degree of functional limitations,
and enable prognostic stratification (27,28). Thus, the 6MWT
was chosen as an evaluation tool in this study. Additionally,
the 6MWT is sensitive for the detection of better exercise
Table 1 - Study participant characteristics.
NIV Control p
Age 42.44 ± 11 46.08 ± 14.23 0.31
Gender
Male n (%) 16 (64.0) 11 (44.0) 0.42
Female n (%) 9 (36.0) 14 (56.0) 0.41
ICU* time (days) 3 [2, 3] 3 [2, 3] 0.49
Hospitalization time (days) 7 [7, 9] 8 [6, 5, 8] 0.12
Preoperative LVEF** (%) 56.84 ± 11.0 57.36 ± 12.1 0.87
ECC*** time (min.) 92.6 ± 41.9 81.65 ± 26.8 0.51
*ICU: Intensive care unit; **LVEF: left ventricular ejection fraction;
***ECC: extracorporeal circulation. Held Test t for parametric variables
(age and LVEF) and Mann-Whitney test for nonparametric ones (ICU time,
hospitalization time and ECC time) and Chi-squared test for the
categorical variable (gender) (*po0.05).
Figure 2 - Comparison of the distance covered IN the 6MWT by
the experimental group (EG) and control group (CG). A t-test was
performed for the independent samples (*po0.05).
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tolerance in patients who are subjected to CPAP during the
postoperative stage of heart valve replacement.
A meta-analysis by Bundchen et al. (16) revealed only
three studies that used NIV after heart failure surgery. The
primary outcome was the distance traveled during the 6MWT,
and all of the studies showed positive results. Wittmer et al.
(29) compared a program of breathing exercises associated
with 30 minutes of CPAP (8 cm H2O) versus only breathing
exercises for a period of 14 days. Chermont (30) compared
30 minutes of CPAP (4-6 cm H2O) versus placebo before
the 6MWT, and Lima et al. (31) showed that the use of CPAP
(10 cm H2O) for 30 minutes before the 6MWT increased
the distance traveled compared to that of the control group
without the use of CPAP. With the same primary outcome,
our study used a different methodological design, com-
prising three one-hour CPAP applications (10 cm H2O)
in the patient who was still hospitalized in the ICU, and
obtained positive results, evidenced by an increase in the
distance walked during the 6MWT carried out at discharge.
This reinforces the idea of making CPAP a standard pro-
cedure in the immediate postoperative period of cardiac
surgery.
Functional capacity is limited in patients with cardiac
disease, not only due to cardiac factors but also due to the
interaction between the cardiopulmonary and musculoske-
letal systems. Abnormal ventilatory responses are common
in these patients, and combined with peripheral muscle
dysfunction, these responses result in greater difficulty in
performing the activities of daily life, especially in the cardiac
postoperative period, which is the focus of our research. NIV
can reduce respiratory effort and increase physical perfor-
mance in such patients by increasing oxygenation in the
microcirculation of peripheral muscles that can lead to
increased intrathoracic pressure, reducing the transmural
pressure of the left ventricle and consequently the pre- and
post-load pressure. This process reflects better contractile
performance of the heart muscle, providing better perfusion
of peripheral tissues, including muscles, and thus causes an
increase in exercise tolerance (9,14-17). This process has been
demonstrated as our primary outcome when patients who
received prophylactic CPAP walked longer distances than
patients who did not receive prophylactic CPAP.
According to Morales-Blanhir et al. (32), through a syste-
matic review of the 6MWT, the average distance traveled by
healthy people is 550 meters. Oliveira et al. (3) affirms that
patients who perform the 6MWT during the cardiac post-
operative stage have an average distance of 375 meters.
A literature review by Zielinska et al. (33) shows that the
6MWT for cardiac patients is a reliable measure and a pre-
dictor of mortality, demonstrating that patients who travel a
distance of fewer than 350 meters have a higher mortality
rate. In a retrospective study using data from 330 surgical
cardiac patients, with 97 of them undergoing heart valve
replacement, La Rovere et al. (34) analyzed pre- and post-
surgery 6MWTresults and obtained values of 256 meters and
381 meters before and after heart valve replacement surgery,
respectively. Our research showed that patients in the NIV
group traveled 334.04 meters, while patients in the control
group reached 264.34 meters. Our results are within the
reference values of the literature; however, these values are
very different from the values for healthy individuals,
demonstrating the great functional loss of cardiac patients,
highlighting the need to maintain cardiac rehabilitation
(phase two) of these patients after hospital discharge.
When evaluating the secondary outcomes of our study,
such as length of stay in the ICU and the total hospital stay of
patients during the postoperative period after heart valve
replacement surgery, no significant differences in these times
were evident between the groups. Trevisan et al. (35), in a
randomized clinical trial, and Landoni et al. (9) and Cabrini
et al. (24), in systematic reviews, showed that the use of NIV
when applied post-extubation does not interfere with the
length of stay in the ICU or in the hospital. In our study, we
found a slight, but not significant, reduction in the number of
days. These data may be explained by the profiles of the
studied patients, who had low EFs, hypoactivity, and impor-
tant muscle strength deficits that were linked to heart failure,
which are factors that the therapeutic tool cannot fully revert.
This study was limited by the absence of a preoperative
evaluation of the distance covered in a 6MWT because the
patients were in a serious health state, debilitated and with
preoperative restrictions. Another limitation was that the
average time for application of CPAP was 60 minutes. This
timeframe suggested the use of BPAP to promote greater
ventilation comfort and thus apply NIV for a longer time and
perhaps under higher pressure. Another limitation was the
absence of variables to evaluate lung function so that we could
correlate the improvement in functionality with the likely
improvement in lung volume and capacity. Thus, we suggest
further research to answer these questions and develop new
therapeutic approaches in cardiac rehabilitation.
As a prophylactic therapeutic approach, NIV has been
confirmed to be effective in improving the functional capa-
city of patients during the postoperative period of heart valve
replacement surgery, as measured by the distance covered in a
6MWT. However, NIV as a therapeutic resource did not affect
the length of stay in the ICU or the length of the total hospital
stay of the studied cardiac patients.
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